Dare Bioscience (DARE) Price to Sales (2022 - 2026)

Dare Bioscience (DARE) has reported Price to Sales for 5 consecutive years, with 170.67 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Price to Sales rose 116.74% year-over-year to 170.67; the trailing twelve-month figure through Jun 2026 stood at 26.85 (up 102.2% YoY), and the FY2025 full-year result was 20.94, down 99.25% from the prior year.
• Price to Sales climbed to 170.67 in Q2 2026 per DARE's latest filing, from 21.08 in the prior quarter.
• Across five years, Price to Sales topped out at 12931.9 in Q3 2025 and bottomed at 1019.39 in Q2 2025.
• Historically, Price to Sales has averaged 1688.06 across 5 years, with a median of 108.03 in 2023.
• The sharpest annual moves came in 2024 and 2025: Price to Sales tumbled 2596.08% in 2024, then surged 1847.05% in 2025.
• Over 5 years, Price to Sales stood at 10.32 in 2022, then jumped by 65.49% to 17.09 in 2023, then sank by 2596.08% to 426.5 in 2024, then surged by 104.94% to 21.08 in 2025, then surged by 709.76% to 170.67 in 2026.
• According to Business Quant data, Price to Sales over the past three periods registered 170.67, 21.08, and 12931.9 for Q2 2026, Q4 2025, and Q3 2025 respectively.